首页 | 本学科首页   官方微博 | 高级检索  
     


Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model
Authors:André P. Fay  A. Ari Hakimi  Martin H. Voss  Nizar M. Tannir  Pheroze Tamboli  Leonard J. Appleman  Joaquim Bellmunt  W. Kimryn Rathmell  Laurence Albiges  James J. Hsieh  Daniel Y. C. Heng  Sabina Signoretti  Toni K. Choueiri
Affiliation:1. Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusetts, USA;2. Pontifical Catholic University of Rio Grande do Sul (PUCRS) School of Medicine, Porto Alegre, Brazil;3. Department of Surgery‐Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA;4. Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA;5. Department of Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA;6. Department of Pathology, MD Anderson Cancer Center, Houston, Texas, USA;7. Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA;8. Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA;9. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France;10. Department of Medical Oncology, Tom Baker Cancer Center and University of Calgary, Calgary, Canada;11. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA
Abstract:
Keywords:Genomics  mRCC  Prognosis  Signature  TCGA
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号